Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers

BACKGROUND: Accurate outcome prediction in neuroblastoma, which is necessary to enable the optimal choice of risk-related therapy, remains a challenge. To improve neuroblastoma patient stratification, this study aimed to identify prognostic tumor DNA methylation biomarkers. RESULTS: To identify gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Decock, Anneleen, Ongenaert, Maté, Hoebeeck, Jasmien, De Preter, Katleen, Van Peer, Gert, Van Criekinge, Wim, Ladenstein, Ruth, Schulte, Johannes H, Noguera, Rosa, Stallings, Raymond L, Van Damme, An, Laureys, Geneviève, Vermeulen, Joëlle, Van Maerken, Tom, Speleman, Frank, Vandesompele, Jo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491423/
https://www.ncbi.nlm.nih.gov/pubmed/23034519
http://dx.doi.org/10.1186/gb-2012-13-10-r95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491423/
https://www.ncbi.nlm.nih.gov/pubmed/23034519
http://dx.doi.org/10.1186/gb-2012-13-10-r95

Ejemplares similares